Nuzenio

Moleculin Biotech Reports

Moleculin Biotech Reports news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 11 latest news signals 7 publisher sources 100/100 entity strength

Latest news

Moleculin Biotech, Inc. Actuals & Estimates (NASDAQ:MBRX) - TradingViewTradingView · Sun, 09 Aug 2026 17:50:54 GMT Moleculin Biotech (MBRX) stake capped at 4.99% under Intracoastal warrants - Stock TitanStock Titan · Thu, 06 Aug 2026 21:27:27 GMT Moleculin Biotech, Inc. (MBRX) CFO buys 293,333 shares and 879,999 warrants - Stock TitanStock Titan · Wed, 05 Aug 2026 20:17:50 GMT Moleculin Biotech, Inc. (MBRX) CEO adds stock and 1.6M Series I warrants - Stock TitanStock Titan · Wed, 05 Aug 2026 20:17:13 GMT Moleculin Biotech (MBRX) CSO buys common stock and Series I Warrants - Stock TitanStock Titan · Wed, 05 Aug 2026 20:16:24 GMT Moleculin reports promising preliminary phase II/III data for leukaemia drug Annamycin - Indian Pharma PostIndian Pharma Post · Tue, 04 Aug 2026 13:56:06 GMT Moleculin reports interim results from MIRACLE trial in r/r AML patients - Clinical Trials ArenaClinical Trials Arena · Mon, 03 Aug 2026 15:49:21 GMT Moleculin Biotech Reports Positive Pivotal Phase 2/3 Trial Results for Annamycin in AML - The Indian PractitionerThe Indian Practitioner · Mon, 03 Aug 2026 12:46:33 GMT

Timeline

Sun, 09 Aug 2026 17:50:54 GMTMoleculin Biotech, Inc. Actuals & Estimates (NASDAQ:MBRX) - TradingView

Thu, 06 Aug 2026 21:27:27 GMTMoleculin Biotech (MBRX) stake capped at 4.99% under Intracoastal warrants - Stock Titan

Wed, 05 Aug 2026 20:17:50 GMTMoleculin Biotech, Inc. (MBRX) CFO buys 293,333 shares and 879,999 warrants - Stock Titan

Wed, 05 Aug 2026 20:17:13 GMTMoleculin Biotech, Inc. (MBRX) CEO adds stock and 1.6M Series I warrants - Stock Titan

Wed, 05 Aug 2026 20:16:24 GMTMoleculin Biotech (MBRX) CSO buys common stock and Series I Warrants - Stock Titan

Tue, 04 Aug 2026 13:56:06 GMTMoleculin reports promising preliminary phase II/III data for leukaemia drug Annamycin - Indian Pharma Post

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

MBRX12 live mentions Inc8 live mentions Moleculin Biotech7 live mentions Stock Titan Moleculin5 live mentions Biotech5 live mentions Stock Titan Stock5 live mentions Titan5 live mentions Moleculin5 live mentions Annamycin3 live mentions AML3 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Moleculin Biotech Reports.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

7 distinct publisher/source names are currently connected to this entity page.